Literature DB >> 11225594

The molecular genetics of hypertrophic cardiomyopathy: prognostic implications.

P Sorajja1, P M Elliott, W J McKenna.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11225594     DOI: 10.1053/eupc.1999.0067

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


× No keyword cloud information.
  6 in total

Review 1.  Gene expression in spermiogenesis.

Authors:  H Tanaka; T Baba
Journal:  Cell Mol Life Sci       Date:  2005-02       Impact factor: 9.261

Review 2.  Genetic counseling and testing for hypertrophic cardiomyopathy: an adult perspective.

Authors:  Cécile Skrzynia; Erin M Demo; Samantha M Baxter
Journal:  J Cardiovasc Transl Res       Date:  2009-09-26       Impact factor: 4.132

3.  Haploinsufficiency of MYBPC3 exacerbates the development of hypertrophic cardiomyopathy in heterozygous mice.

Authors:  David Barefield; Mohit Kumar; Joshua Gorham; Jonathan G Seidman; Christine E Seidman; Pieter P de Tombe; Sakthivel Sadayappan
Journal:  J Mol Cell Cardiol       Date:  2014-11-25       Impact factor: 5.000

4.  Mutations of the beta myosin heavy chain gene in hypertrophic cardiomyopathy: critical functional sites determine prognosis.

Authors:  A Woo; H Rakowski; J C Liew; M-S Zhao; C-C Liew; T G Parker; M Zeller; E D Wigle; M J Sole
Journal:  Heart       Date:  2003-10       Impact factor: 5.994

5.  Mutation of the MYH7 gene in a child with hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome.

Authors:  Waldemar Bobkowski; Małgorzata Sobieszczańska; Anna Turska-Kmieć; Agnieszka Nowak; Józef Jagielski; Marzena Gonerska; Arleta Lebioda; Aldona Siwińska
Journal:  J Appl Genet       Date:  2007       Impact factor: 3.240

Review 6.  The MOGE(S) classification : A TNM-like classification for cardiomyopathies.

Authors:  E Şahan; S Şahan; M Karamanlıoğlu; M Gul; O Tufekcioğlu
Journal:  Herz       Date:  2016-01-25       Impact factor: 1.443

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.